ArticleJournal of translational medicine2021

Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts.

Jeonghyeon Moon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.